Sinphar Pharmaceutical Co. Ltd. | Balance Sheet
Fiscal year is January-December. All values TWD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
894
1,327
1,024
1,140
1,164
975
Total Accounts Receivable
508
544
549
572
527
572
Inventories
802
883
718
633
534
503
Other Current Assets
30
32
29
17
33
72
Total Current Assets
2,234
2,785
2,320
2,363
2,259
2,122
Net Property, Plant & Equipment
3,205
3,298
3,395
3,361
3,339
3,384
Total Investments and Advances
87
120
252
90
103
59
Long-Term Note Receivable
47
-
-
-
-
-
Intangible Assets
40
186
335
304
261
218
Other Assets
51
56
59
55
54
60
Total Assets
5,703
6,464
6,387
6,206
6,043
5,878
ST Debt & Current Portion LT Debt
618
503
422
388
345
Accounts Payable
139
98
152
185
155
Income Tax Payable
51
42
24
12
22
Other Current Liabilities
412
491
425
348
329
Total Current Liabilities
1,219
1,134
1,022
934
851
Long-Term Debt
805
1,039
1,054
1,212
1,403
Provision for Risks & Charges
143
147
150
110
93
Deferred Taxes
40
24
12
33
28
Other Liabilities
41
22
163
168
69
Total Liabilities
2,209
2,385
2,426
2,424
2,416
Common Equity (Total)
3,008
3,304
3,219
3,092
3,075
Total Shareholders' Equity
3,008
3,304
3,219
3,092
3,075
Total Equity
3,494
4,079
3,960
3,782
3,627
Liabilities & Shareholders' Equity
5,703
6,464
6,387
6,206
6,043
Accumulated Minority Interest
486
774
742
690
552
About Sinphar Pharmaceutical Co.
View Profile
